Live Science on MSN4d
Hims & Hers Super Bowl controversy: What the ad left out about its 'alternative' weight-loss drugs
The telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide medications aren't FDA-approved.
Judge orders HHS, CDC and FDA to restore deleted webpages with health information
The NGO Doctors for America argued that HHS, CDC and FDA violated federal law in removing medical information from ...
Potentially fatal contaminant may be in H-E-B tuna. Here's what to trash.
Tri-Union Seafoods issued the voluntary recall on the products Friday out of "an abundance of caution" over botulism risk.
The Trump administration restores federal webpages after court order
DFA alleges that the agencies violated the Administrative Procedure Act and the Paperwork Reduction Act by removing public ...
Judge orders health agencies to restore data scrubbed by Trump administration
A judge ordered federal health agencies Tuesday to restore online datasets taken down after President Trump issued an ...
Federal health agencies restore webpages and datasets following judge’s order
Federal health agencies have restored several webpages and datasets, following a judge’s order to bring back public access to ...
Senators call on FDA to act against misleading weight-loss drug commercials
Commercials run by the telehealth company Hims & Hers have been placed under the microscope as lawmakers are calling out the advertisement of prescriptions for injectable weight-loss drugs without ...
Biodexa Pharmaceuticals ADRs Rise After Cancer Drug Gets FDA Fast-Track Designation
The U.K. biopharmaceutical company said data from a Phase 2 study of eRapa, a treatment for familial adenomatous polyposis, showed the drug to be safe and well-tolerated among users. The treatment ...
What’s the Difference Between the FDA and the USDA?
Explaining America’s weirdly complicated food inspection system, including who regulates poultry and eggs and how Robert F. Kennedy Jr. is involved ...
STAT13h
Pharmalittle: We’re reading about FDA morale, pharma removing DEI goals, and more
Reports of impending layoffs, a buyout offer, and a return-to-office mandate have put a damper on FDA staff morale ...
JD Supra1d
A Model’s Credibility Is in the Details: FDA Draft Guidance on the Use of AI Models in Drug and Biological Product Development
In January, the U.S. Food and Drug Administration (FDA) issued its first guidance on the use of artificial intelligence (AI) models in ...
Cure Today3d
An Expert Breaks Down What DPD Is and Labeling Updates From The FDA
Dr. Gabriel A. Brooks discusses the recent FDA product labeling update for Xeloda and 5-FU which aims to highlight risks associated with DPD deficiency.